TY - JOUR ID - 132948 TI - In silico evaluation of surface-exposed proteins of severe acute respiratory syndrome coronavirus 2 to propose a multi-epitope vaccine candidate JO - Health Biotechnology and Biopharma (HBB) JA - HBB LA - en SN - Y1 - 2021 PY - 2021 VL - 4 IS - 4 SP - 51 EP - 72 KW - SARS-CoV-2 KW - Spike glycoprotein KW - membrane protein KW - multiepitope-based subunit vaccine KW - In Silico DO - 10.22034/HBB.2021.06 N2 - The novel Coronavirus disease 2019 caused a global outbreak therefore a promising vaccine is needed to combat it. In this study, the Spike (S) glycoprotein, Membrane (M) protein, and Envelope (E) protein have been tested as putative vaccine candidates. It was demonstrated that the second protrusion part of M protein contains several immunogenic epitopes. On the other hand, the S2 domain of S protein was found to be highly conserved. Therefore, we proposed a fusion protein as a multiepitope-based subunit vaccine including the second protrusion part of M protein and S2 domain of S protein with a flexible linker. Finally, the 3D structure and physicochemical properties of this fusion protein were evaluated to select a stable structure. UR - https://www.healthbiotechpharm.org/article_132948.html L1 - https://www.healthbiotechpharm.org/article_132948_5bdf1d60e2e9ae308a4f2376df515e3b.pdf ER -